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Introduction:Blood-borne infectious agents are one of the main anxieties of Blood 
Transfusion Organization in all countries. According to WHO, the blood healthy and blood 
safety is included ensuring and monitoring of quality and efficiency for all patients requiring 
blood transfusion. We at the current study intend that survey prevalence HIV Ab, HCV Ab, 
HBS Ag Among blood donors refer to the Blood Transfusion Organization of Ilam in 2010-
2011. 
Materials and methods:The sample size was folders of 4005 subjects who entered into the 
study with census method. Screening test was performed for hepatitis B surface antigen, 
Antibodies against hepatitis C virus and HIV Ab. For confirmed positive result that obtain by 
screening test we use for HBV, HCV, HIV respectively. 
Results: Number (percent) of subjects  with hepatitis B (HBV), hepatitis C (HCV) and HIV 
among the infected blood donors were 29 (70.7%), 11 (26.8%) and 1 (2.5%), respectively. 
There was no significant association between education level and disease (P>0.05), 
Significant correlation (P<0.01) was found between job variables and disease 
Conclusion: The low prevalence of HIV infection in this study and other similar studies in 
Iran May be due to the higher percentage of more regular volunteer donors in Iran As the 
World Health Organization studies show that voluntary donors are with the lowest prevalence 
of HIV, hepatitis viruses and other blood-borne infections 
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Introduction 
In spite of the blood transfusion and 
process of receiving blood products are the 
only ways to save the patient's at the 
sometime, however, some pathogen 
transfer from this way (1). The main goal 
of the Blood Transfusion Organization, 
provide an adequate and safe blood for 
regular and conditions. Transfusion-
transmitted bacterial infection and 
contaminated blood products with bacteria 
is a main concern of Blood Transfusion 
Organization worldwide. The use of 
greater amount of blood transfusion is 
associated with a transfusion-transmitted 
bacterial infection particularly for HIV and 
Hepatitis viruses (2,3). 
There are many steps taken to ensure 
quality of the blood products, at first, 
perfect Health history obtained in order to 
inspection primary health. All Blood 
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donors are tested in terms of HBS, HIV 
Ab, HCV Ab, syphilis, and in some parts 
of  in order to antibodies HTLV-I and II 
(4). According to WHO, the blood healthy 
and blood safety is included ensuring and 
monitoring of quality and efficiency for all 
patients requiring blood transfusion (5). 
Thus the eventually purpose of these 
strategies is reduce risk of the transfusion-
transmitted bacterial infection (6). 
Blood Transfusion Organization Strategies 
for reduce the risk of transfusion-
transmitted bacterial infection through 
blood and blood products transfusion are 
various. Strategies including Public 
education about of blood-borne diseases, 
Recommendations to blood donors in 
order to the study manuals and posters that 
is containing general and special 
conditions of blood transfusion, Medical 
examination and investigate apparent 
health blood donors by the doctor, to 
questions by doctor about the history of 
diseases, especially viral diseases, 
possession of drug injection and uncertain 
sexual risk behaviors. Also could mention 
to the confidential self-exclusion system 
(7,8). 
In our country for the screening of donated 
blood in term of HBS.Ag, HCV.Ab, HIV 
Ab, at the beginning use enzymatic 
methods (ELISA). Afterward positive 
sample been re-evaluated by a 
confirmatory system that is for HBV by 
neutralization, HIV by western blots and 
for HCV by RIBA method. 
Since the volunteer blood donors are 
samples of the normal population, 
epidemiologic study of HIV and hepatitis 
viruses can represent the overall state of 
susceptibility to these diseases in the 
public. In addition by identifying high-risk 
populations could carry out careful 
planning in order to prevent this disease. 
Therefore, in current study we intend that 
analysis prevalence of  HIV Ab،HCV Ab, 
HBS Ag among blood donors refer to the 
Blood Transfusion Organization in Ilam 
city (2010-2011). 
Materials and methods  
We conducted a cross-sectional study 
based on medical records. We recruited all 
blood donors that referred to donate blood 
to the Elam Blood Transfusion 
Organization on 2010-2011. Total sample 
size was 4005 subjects who entered into 
the study with use of census method. 
Evaluated  variables in  this research were 
the number of blood donors, demographic 
characteristics (age, sex, marital status, 
education and occupation) and  the results 
of confirmatory HIV Ab, HCV Ab, HBS 
Ag tests of all blood donors. Chi square 
test used for  data analysis with the 
statistical software of SPSS. Screening test 
for hepatitis B surface antigen, antibodies 
against hepatitis C virus and HIV Ab were 
commercial kits from Biorad and Avicena, 
respectively. 
Confirmed tests included Behring 
(German) Innogenetic, RIBA, MP 
Diagnostica ( western blot) for HBV, 
HCV, HIV were used respectively. 
Results 
Among all studied population, 3516 
(87.8%) of them were males and 489 
(12.2%) were female. In terms of 
education level, 148 (3.7%) were illiterate, 
929 (23.2%) without the college degree, 
1542 (38.5%) diploma, 601 (15%) 
associated degree, 709 (17.7%) bachelor, 
52 (1.3%) MS and 24 (0.6%) had a PhD. 
From the point of view job, 1446 (36.1%) 
self-employed worker, 953 (23.8%) 
employee, 541 (13.5%) students, 72 
(1.8%) soldier, 216 (5.4 %) military jobs, 
376 patients (9.4%) unemployed, 72 
(1.8%) labor 329 (8.2%) was housewives. 
Also 1622 (40.5%) married, and 2383 
patients (59.5%) were unmarried. 
Prevalence of infection with hepatitis B 
(HBV), hepatitis C (HCV) and HIV in 
blood donors, 29 patients (70.7%), 11 
(26.8%) and 1 (2.5%), respectively. 
The results of this study shows that there 
was a significant association between sex 
and disease variables (P<0.05) so the 




disease was more prevalent in males. 
There was no significant association 
between education level and disease 
(P>0.05), Significant correlation (P<0.01) 
was found between job variables and 
disease. Also the outbreak at the   self-
employed worker was more people than 
other occupational groups. Significant 
association between marital status and 
disease (P<0.05) were found and There 
was much sickness among married than 
unmarried people. 
The ultimate goal of all blood centers is to 
provide safe and adequate blood and blood 
products and to minimize the risk of 
infection transmitted through blood and 
one of the best ways to promote donated 
blood healthy is choice safe donors in any 
circumstance (9). According to this study, 
41 blood donors were diagnosed with viral 
illnesses. The largest number, 29 (70.7%) 
were associated with hepatitis B virus. 
During the previous study at the years 
1997 and 1998, in order to diagnosis of 
HBV at the patients referred to the Blood 
Transfusion Center of Ilam, Prevalence of 
hepatitis B among patients was 2.3% and 
2.9% respectively (10). According to 
previous epidemiological study, Iran is 
lactated to area with a medium-prevalence 
of the hepatitis B. The basis one of the best 
seroepidmiological studies in which the 
taken in all age groups, the prevalence of 
HBsAg is estimated 1.7% (11). In a study 
on the prevalence of viral infections in 
blood donors referred to the Gorgan blood 
transfusion organization, of 38920 
volunteer blood donors, the amount 
estimated is 886 patients (2.3%) (12). Also 
in studies conducted in Mashhad (13), 
Tehran (14), jahrom (15) has been reported 
respectively, 1.17, 0.6 and 0.4%. 
Hepatitis C is the most common hepatitis 
following blood transfusion in some 
countries such as Japan. America and 
Western Europe has been responsible for 
90 % of all cases of HCV. In our study we 
found 11 cases (26.8%) were infected with 
hepatitis C virus (16) . 
The most common and the most important 
way for infected with this disease has been 
receiving blood products contaminated 
with hepatitis C virus (17). 
Other studies in this context was 
performed in Mashhad (13), Tehran (14), 
jahrom (15) and Gorgan (12), and results 
shows that prevalence of HCV infection 
were 0.1, 0.2, 0.3 and 0.6%, respectively. 
Numerous studies throughout worldwide 
have been shown that prevalence of HCV 
in the general population, which are often 
volunteers, from 0.16 to 6 %. Alavian et al 
found that the prevalence of HCV among 
Iranian donors (by using confirmatory test) 
was less than 0.2 percent (18). 
Based on our results, only one case (2.5%)  
was observed with HIV infection which is 
similar to other studies .In other previous 
reports HIV infection in blood donors 
were 0.003 (14), zero (12,15), 0.05 (19), 
0.008 (20), 0.017 (21) and 5.5% (22). 
Similar studies in Italy, France and 
America from the years 1995-2002 shows 
significant reductions a possible 
explanation for this might be that lifestyle 
changes and reduce of the prevalence  of 
HIV and also careful screening of blood 
donors (23-25(. 
The number of people living with HIV 
infection worldwide is increasing and has 
been in 2009 to 33.3 million, i.e. more 
than 23% in 1999. In 2009, 2.6 million 
new HIV infections and 1.8 million deaths 
from HIV/AIDS are estimated. At 2009, 
incidence of new cases of HIV infection 
have been 19% lower than in 1999 that 
reflecting the greater than before efficacy 
of anti-HIV drug to extend the life of these 
patient people (26). 
The results of other reports showed that 
the incidence of viral infections was higher 
in men that are married and self-employed 
worker which is similar to the results of 
other studies (10,19). However in some 
studies, infection was higher in single and 
self-employed (13). In some other studies, 
the prevalence was similar in both sexes 
(14). In the present study, there was no 
significant association between the disease 




and education level. While in some studies 
the disease was common in those with less 
education diploma (14), which indicates 
the importance of awareness of the disease 
and its effect on the prevalence or 
prevention of disease. 
The low prevalence of HIV infection in 
this study and other similar studies in Iran 
May be due to the higher percentage of 
more regular volunteer donors in Iran. A 
world Health Organization study shows 
that voluntary donors are with the lowest 
prevalence of HIV, hepatitis viruses and 
other blood-borne infections. Another 
important point is that blood can be a good 
way to detect the disease in people who 
are not aware of their infection. 
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